October 31st 2016EP. 1: Persistent and Recurrent Atopic Dermatitis
October 31st 2016EP. 2: Atopic Dermatitis: Current and Future Management
October 31st 2016EP. 3: Weighing Quality of Life Improvements in Atopic Dermatitis
October 31st 2016EP. 4: Understanding Emerging Therapies in Atopic Dermatitis
October 31st 2016EP. 5: Measuring Outcomes in Atopic Dermatitis
October 31st 2016EP. 6: Atopic Dermatitis: Cost and Value
October 31st 2016EP. 7: Atopic Dermatitis: Reimbursement Challenges
October 31st 2016EP. 8: Identifying the Appropriate Patients for Atopic Dermatitis Treatments
October 31st 2016EP. 9: Atopic Dermatitis: Determining Utilization Management Criteria for Long-Term Systemic Therapies
October 31st 2016EP. 10: Evidence and Outcomes in Atopic Dermatitis
October 31st 2016EP. 11: Practical Application of Clinical Trial Measures in Atopic Dermatitis
October 31st 2016EP. 12: Utilization Management Nuances in Atopic Dermatitis
October 31st 2016EP. 13: Atopic Dermatitis: Evolving Role of Specialty Pharmacy
October 31st 2016EP. 14: Specialty Pharmacy, Payer Goals in Atopic Dermatitis Management
October 31st 2016EP. 15: The Future of Atopic Dermatitis
October 31st 2016EP. 16: One Patient's Journey With Atopic Dermatitis
October 31st 2016EP. 17: Impact of Atopic Dermatitis on Day-to-Day Life
October 31st 2016EP. 18: Atopic Dermatitis: Dupilumab and Increase in Patient Quality of Life
October 31st 2016EP. 19: Atopic Dermatitis: One Patient's Experience With Instructions Regarding Use of Dupilumab
October 31st 2016EP. 20: Advice for Patients With Atopic Dermatitis
